Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2009,NCI,5R01CA103937-05,,Molecular Diagnostics for Malignant Effusion,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$338,148"
Ovarian Cancer,2009,NCI,5R01CA124630-03,,PTTG Role in Ovarian Tumorigenesis and Matastasis,"KAKAR, SHAM",UNIVERSITY OF LOUISVILLE,KY,"$253,080"
Ovarian Cancer,2009,NCI,5R01CA123233-02,,Regulation of JNK-signaling molecules by the gep oncogenes,"DHANASEKARAN, DANNY",TEMPLE UNIVERSITY,PA,"$280,125"
Ovarian Cancer,2009,NCI,5R01CA119200-03,,Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model,"BARTON, JENNIFER",UNIVERSITY OF ARIZONA,AZ,"$282,735"
Ovarian Cancer,2009,NCI,5R01CA131407-02,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$345,888"
Ovarian Cancer,2009,NCI,5F31CA126474-03,,Role of Src in Stress-Mediated Progression of Ovarian Cancer,"ARMAIZ-PENA, GUILLERMO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$27,032"
Ovarian Cancer,2009,NCI,5R01CA039742-25,,Epidemiology of Cancer in a Cohort of Older Women,"FOLSOM, AARON",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$525,317"
Ovarian Cancer,2009,NCI,5R01CA109619-05,,Polyamine Catabolism in Platinum Drug Action,"PENDYALA, LAKSHMI",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$301,591"
Ovarian Cancer,2009,NCI,5R01CA111914-05,,Ovarian Cancer and Mismatch Repair Deficiency,"PAL, TUYA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$333,818"
Ovarian Cancer,2009,NCI,5R01CA114343-03,,Haplotype-Based Genome Screen for Ovarian Cancer Loci,"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$1,815,286"
Ovarian Cancer,2009,NCI,5R01CA132091-02,,Targeted Nanoparticle DNA Therapy for Ovarian Cancer,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$261,914"
Ovarian Cancer,2009,NIGMS,5R01GM052418-10,,Mass Spectrometry Studies on Radical Reactions of DNA,"KENTTAMAA, HILKKA",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$216,077"
Ovarian Cancer,2009,NCI,5R01CA079756-09,,P53-Mediated G1/M Checkpoint Controls Altered by PPM1D,"BUCHBERG, ARTHUR",THOMAS JEFFERSON UNIVERSITY,PA,"$238,892"
Ovarian Cancer,2009,NINR,5R21NR010571-02,,The Feasibility of Earlier Detection of Ovarian Cancer Using Symptom Reports,"ANDERSEN, M",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$248,437"
Ovarian Cancer,2009,NCI,5R01CA123197-03,,Death Receptor-mediated Apoptosis and Therapy Strategies in Ovarian Cancer,"ZHOU, TONG",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$450,917"
Ovarian Cancer,2009,NCI,5R01CA120409-04,,Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells,"JUNE, CARL",UNIVERSITY OF PENNSYLVANIA,PA,"$266,186"
Ovarian Cancer,2009,NCI,1R15CA137499-01,,RECRUITMENT OF BONE MARROW HEMATOPOIETIC STEM CELLS TO TUMORS,"BENENCIA, FABIAN",OHIO UNIVERSITY ATHENS,OH,"$221,250"
Ovarian Cancer,2009,NCI,5R01CA060651-17,,Mouse Models to Study Gonadal Tumor Development,"MATZUK, MARTIN",BAYLOR COLLEGE OF MEDICINE,TX,"$266,562"
Ovarian Cancer,2009,NCI,2R01CA104996-05A1,,Promoting Tumor Immunity by Cross-linking B7-DC,"PEASE, LARRY","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$246,712"
Ovarian Cancer,2009,NCI,5R01CA111882-04,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$264,562"
Ovarian Cancer,2009,NCI,1R01CA133057-01A1,,Prognostic markers for ovarian cancer,"MOK, SAMUEL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$319,550"
Ovarian Cancer,2009,NCI,5R01CA129080-02,,The Roles of HBXAP Gene in Ovarian Cancer,"SHIH, IE-MING",JOHNS HOPKINS UNIVERSITY,MD,"$340,300"
Ovarian Cancer,2009,NCI,1R21CA137686-01,,High-throughput intracellular microrheology: a new tool for cancer research,"WIRTZ, DENIS",JOHNS HOPKINS UNIVERSITY,MD,"$241,200"
Ovarian Cancer,2009,NCI,5R01CA116674-04,,Epigenetic regulation of cancer/germ-line antigen gene expression,"KARPF, ADAM",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$278,984"
Ovarian Cancer,2009,NIGMS,5F32GM084587-02,,Mechanism of homology search in homologous recombination by Rad51 and Rad54.,"MOSES, DANA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$47,210"
Ovarian Cancer,2009,NCI,1R01CA134424-01A1,,A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc,"KOSTUK, RAYMOND",UNIVERSITY OF ARIZONA,AZ,"$429,050"
Ovarian Cancer,2009,NCRR,1S10RR024650-01A1,,Tansmission Electron Microscope for Analytical Micoscopy,"TODD, GORDON",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$376,635"
Ovarian Cancer,2009,NICHD,1R01HD057110-01A2,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",YALE UNIVERSITY,CT,"$77,921"
Ovarian Cancer,2009,NCI,5R01CA051578-17,,A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$236,153"
Ovarian Cancer,2009,NCRR,1S10RR024544-01A1,,HyperSense System for Molecular Imaging,"RIZI, RAHIM",UNIVERSITY OF PENNSYLVANIA,PA,"$500,000"
Ovarian Cancer,2009,NCI,5R01CA123249-02,,Regulation of Serine Protease HtrA1 and Chemoresponse,"SHRIDHAR, VIJI","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$313,533"
Ovarian Cancer,2009,NCI,5R01CA106713-05,,Mechanism of SHeA2 Action in Ovarian Cancer,"BENBROOK, DORIS",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$272,533"
Ovarian Cancer,2009,NCI,5R01CA123219-02,,The Role of Aberrant Splicing of EVl1 in Ovarian Cancer Pathophysiology,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$314,578"
Ovarian Cancer,2009,NCI,5R01CA107506-05,,Novel human gene-IG20-potential role in cancer therapy,"PRABHAKAR, BELLUR",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$261,235"
Ovarian Cancer,2009,NHGRI,5R01HG004064-03,,Do Physicians Understand Uncertain Variants and Other Genetic Test Results?,"PLON, SHARON",BAYLOR COLLEGE OF MEDICINE,TX,"$331,088"
Ovarian Cancer,2009,NCI,5R01CA112291-05,,"BRIT 1: Roles in Immortalization, Checkpoints and Cancer","LIN, SHIAW-YIH",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$252,809"
Ovarian Cancer,2009,NIGMS,5R01GM073823-04,,Functions for Myosin VI in the kidney proximal tubule,"MOOSEKER, MARK",YALE UNIVERSITY,CT,"$324,830"
Ovarian Cancer,2009,NCI,5R01CA106878-05,,Biomarkers with Biological Function in Ovarian Carcinoma,"SKUBITZ, AMY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$274,365"
Ovarian Cancer,2009,NCI,1F32CA138153-01,,Multimodality Microendoscope for Metastatic Ovarian Cancer Detection & Treatment,"EVANS, CONOR",MASSACHUSETTS GENERAL HOSPITAL,MA,"$47,210"
Ovarian Cancer,2009,NCI,5R01CA105207-05,,Plasmacytoid dendritic cell behavior in ovarian cancer,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$273,408"
Ovarian Cancer,2009,NCI,5U10CA027469-29,,Gynecologic Oncology Group,"DISAIA, PHILIP",GYNECOLOGIC ONCOLOGY GROUP,MD,"$9,825,062"
Ovarian Cancer,2009,NCI,5R01CA111786-05,,Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction,"RABINOWICH, HANNAH",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$267,772"
Ovarian Cancer,2009,NCI,7R03CA133915-02,,Dietary Intervention in the Gallus Domesticus Model of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$81,262"
Ovarian Cancer,2009,NCI,5R01CA107195-05,,Loss of Vitamin A Metabolism in Ovarian Oncogenesis,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$284,831"
Ovarian Cancer,2009,NCI,5R01CA124515-03,,Vascular Leukocytes influence the tumor microenvironment,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$303,810"
Ovarian Cancer,2009,NCI,5R01CA085289-06,,DNA Methylation and Ovarian Cancer,"NEPHEW, KENNETH",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$255,015"
Ovarian Cancer,2009,NCI,5R01CA125636-03,,The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$314,279"
Ovarian Cancer,2009,NCI,5R01CA086984-10,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$223,262"
Ovarian Cancer,2009,NCI,5K08CA106597-04,,Chromatin structure and BRCA1 Checkpoint Function,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$135,677"
Ovarian Cancer,2009,NCI,5R01CA112162-05,,The role of complement in ovarian cancer,"LAMBRIS, JOHN",UNIVERSITY OF PENNSYLVANIA,PA,"$296,817"
Ovarian Cancer,2009,NCI,5R01CA115483-05,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$299,843"
Ovarian Cancer,2009,NCI,5R01CA094172-08,,Molecular Pathogenesis of Ovarian Endometrioid Adenocarcinomas,"CHO, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$261,178"
Ovarian Cancer,2009,NCI,5R01CA112523-04,,Steroid Hormone Genes and Ovarian Cancer Risk,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$681,317"
Ovarian Cancer,2009,NCI,5R01CA120429-03,,Regulation of MDR1 Expression and Drug Resistance by CD44,"RODRIGUEZ-RODRIGUEZ, LORNA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$296,400"
Ovarian Cancer,2009,NCI,5R01CA111334-05,,Vitamin D and Ovarian Cancer Prevention and Treatment,"BAI, WENLONG",UNIVERSITY OF SOUTH FLORIDA,FL,"$244,382"
Ovarian Cancer,2009,NCI,5R01CA112570-06,,Progesterone-mediated protection against ovarian cancer,"HO, SHUK-MEI",UNIVERSITY OF CINCINNATI,OH,"$258,707"
Ovarian Cancer,2009,NCI,5R01CA106414-05,,Population-Based Analysis of Ovarian Cancer Biomarkers,"SUTPHEN, REBECCA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$565,056"
Ovarian Cancer,2009,NCI,5R01CA086061-09,,Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticance,"ESSIGMANN, JOHN",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$229,421"
Ovarian Cancer,2009,NCI,5R01CA121187-03,,Monitoring of advanced virotherapy for ovarian cancer,"CURIEL, DAVID",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$275,500"
Ovarian Cancer,2009,NCI,5R01CA131183-02,,"RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression","LIU, JINSONG",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$255,640"
Ovarian Cancer,2009,NCI,7R01CA111436-04,,Regulation of BRCA1 Function by Protein Phosphatase 1,"HSU, LIH-CHING",NATIONAL TAIWAN UNIVERSITY,TAIWAN,"$132,101"
Ovarian Cancer,2009,NCI,1R01CA138762-01,,Splicing factors as therapeutic targets for the treatment of ovarian cancer,"BECK, WILLIAM",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$314,066"
Ovarian Cancer,2009,NCI,5R01CA109545-04,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$243,511"
Ovarian Cancer,2009,NCI,1R01CA139159-01,,Signal Transduction Enzyme Inhibitors from Extremophilic Microbes as Anticancer A,"STIERLE, ANDREA",MONTANA TECH OF THE UNIVOF MONTANA,MT,"$204,868"
Ovarian Cancer,2009,NCI,5R01CA108990-05,,Multianalyte Assay For Early Diagnosis Of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$516,514"
Ovarian Cancer,2009,NCI,5R01CA123170-04,,MUC-1 related cancer immunity: determinants and predictive significance,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$274,214"
Ovarian Cancer,2009,NCI,5K25CA120350-03,,A near-infrared contrast agent for targeted imaging of cancer,"ROMANOWSKI, MAREK",UNIVERSITY OF ARIZONA,AZ,"$137,959"
Ovarian Cancer,2009,NCI,5R01CA118213-04,,Pharmacokinetic strategies to optimize IP chemotherapy,"BALTHASAR, JOSEPH",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$255,967"
Ovarian Cancer,2009,NCI,5R01CA017393-34,,Mullerian Inhibiting Substance,"DONAHOE, PATRICIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$323,922"
Ovarian Cancer,2009,NCI,5R01CA127913-02,,MyD88-bearing tumors in immune-regulation and chemo-resistance,"MOR, GIL",YALE UNIVERSITY,CT,"$343,413"
Ovarian Cancer,2009,NCI,1R01CA131965-01A2,,Defining a Pre-Malignant Phenotype in Fallopian Tube Epithelium,"SWISHER, ELIZABETH",UNIVERSITY OF WASHINGTON,WA,"$323,700"
Ovarian Cancer,2009,NCI,2R01CA095175-06A1,,Analysis of BRCA1 recombination functions,"SCULLY, RALPH",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$304,354"
Ovarian Cancer,2009,NCI,5R01CA118158-04,,The role of BRCA1 in nonhomologous repair of chromosomal double-strand breaks,"XIA, FEN",VANDERBILT UNIVERSITY,TN,"$238,105"
Ovarian Cancer,2009,NCI,2R01CA101850-05A1,,ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING,"BAE, YOU",UNIVERSITY OF UTAH,UT,"$271,181"
Ovarian Cancer,2009,NCI,5R01CA119078-04,,CELL NON-AUTONOMOUS MODE OF TUMOR SUPPRESSION BY BRCA1,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$224,748"
Ovarian Cancer,2009,NCI,2R01CA109298-05,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$381,050"
Ovarian Cancer,2009,NCI,5R01CA114037-03,,Taxane Resistance in Breast and Ovarian Cancer Cells,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$297,730"
Ovarian Cancer,2009,NCI,5R01CA122728-02,,Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$346,357"
Ovarian Cancer,2009,NCI,5R41CA128145-02,,OVARIAN CANCER PROTEOME VIA TISSUE MICRODISSECTION AND GEMINI TECHNOLOGIES,"SAXENA, SATYA","CALIBRANT BIOSYSTEMS, INC.",MD,"$260,279"
Ovarian Cancer,2009,NCI,1R21CA135130-01A1,,Peritumorally transformable nanoparticles for intraperitoneal chemotherapy of ova,"YEO, YOON",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$166,126"
Ovarian Cancer,2009,NCI,1R21CA132987-01A2,,Risk of Cancer with Incidental Findings Identified on Ultrasound Imaging,"SMITH-BINDMAN, REBECCA",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$220,213"
Ovarian Cancer,2009,NCI,1R01CA136549-01A1,,Regulation of the ATM/ATR-p53 DNA Damage Signaling Pathway by the Wip1 Phosphatas,"LU, XIONGBIN",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$298,800"
Ovarian Cancer,2009,NCI,5K24CA087933-09,,Clinical Investigator Development in Solid Tumor Oncology,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$153,090"
Ovarian Cancer,2009,NCI,1R01CA136891-01A1,,A Pooled Analysis to Identify New Ovarian Cancer Risk Factors,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$350,489"
Ovarian Cancer,2009,NCI,5R03CA132573-02,,Inflammatory Processes and Depression in a Syngeneic Model of Ovarian Cancer,"LAMKIN, DONALD",UNIVERSITY OF IOWA,IA,"$75,000"
Ovarian Cancer,2009,NCI,5R21CA133877-02,,A Low-Dose Decitabine Strategy for Restoring Ovarian Cancer Sensitivity,"MATEI, DANIELA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$341,244"
Ovarian Cancer,2009,NCI,7R01CA121119-03,,Autocrine Wnt signaling in human breast and ovarian cancer cells,"BAFICO, ANNA",CARDIFF UNIVERSITY,UK,"$205,200"
Ovarian Cancer,2009,NCI,5R01CA116779-04,,Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$271,456"
Ovarian Cancer,2009,NCI,5R01CA113891-04,,BARD1 phosphorylation in breast and ovarian cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$218,696"
Ovarian Cancer,2009,NCI,5R01CA092520-09,,Tumor Host Range Mutants of Polyoma and Their Targets,"BENJAMIN, THOMAS",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$634,992"
Ovarian Cancer,2009,NCI,5R01CA092889-08,,Role of TGFbeta in Microtubule Dynamics,"MULDER, KATHLEEN",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$265,650"
Ovarian Cancer,2009,NCI,5R01CA130911-02,,Chimeric NKG2D receptors in ovarian cancer immunotherapy,"SENTMAN, CHARLES",DARTMOUTH COLLEGE,NH,"$331,793"
Ovarian Cancer,2009,NCI,5R01CA118678-03,,Apoptotic regulators in ovarian cancer,"MOR, GIL",YALE UNIVERSITY,CT,"$314,450"
Ovarian Cancer,2009,NCI,5R01CA122581-04,,Tumor-Associated Antigens in Early Stage Serous Carcinoma,"RODEN, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$258,389"
Ovarian Cancer,2009,NCI,5R01CA112354-05,,Modeling ovarian carcinoma by defined genetic alterations,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY ITHACA,NY,"$266,292"
Ovarian Cancer,2009,NCI,5R21CA132016-02,,Evaluation of hGBP-1 as a marker for paclitaxel resistance in ovarian cancer,"VESTAL, DEBORAH",UNIVERSITY OF TOLEDO,OH,"$162,000"
Ovarian Cancer,2009,NHLBI,5R01HL090559-03,,Bayesian Modeling and Optimal Design for Studies of Gene-Environment Association,"IVERSEN, EDWIN",DUKE UNIVERSITY,NC,"$312,000"
Ovarian Cancer,2009,NCI,5R01CA127562-03,,Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer,"UENO, NAOTO",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$292,600"
Ovarian Cancer,2009,NCI,5R01CA119388-05,,Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$487,364"
Ovarian Cancer,2009,NCI,5R01CA075334-12,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$102,771"
Ovarian Cancer,2009,NCI,5R01CA118578-05,,The Mechanism of BRCA1 in Tumor Suppression,"HU, YANFEN",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$245,846"
Ovarian Cancer,2009,NCI,5U01CA111273-05,,Affinity-based Seurm Proteomics: Breast/Ovarian Cancer,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$543,158"
Ovarian Cancer,2009,NCI,5R01CA122443-03,,Genetic Variation in the NF-kappaB Pathway and Ovarian Cancer Etiology,"GOODE, ELLEN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$550,286"
Ovarian Cancer,2009,NCI,5R01CA118846-03,,Regulation of gene silencing by exogenous sphingosine,"SCHMELZ, EVA",VIRGINIA POLYTECHNIC INST AND ST UNIV,VA,"$271,035"
Ovarian Cancer,2009,NCI,5K25CA128666-03,,Comparative Proteomics Applied to the Avian Model of Ovarian Cancer,"HAWKRIDGE, ADAM",NORTH CAROLINA STATE UNIVERSITY RALEIGH,NC,"$143,370"
Ovarian Cancer,2009,NIA,5R03AG032602-02,,Prophylactic oophorectomy: practice patterns & outcomes,"CHAN, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$63,549"
Ovarian Cancer,2009,NCI,5R01CA135312-02,,Dendritic nanomedicine for cancer imaging and treatment,"TUNG, CHING-HSUAN",METHODIST HOSPITAL RESEARCH INSTITUTE,TX,"$311,250"
Ovarian Cancer,2009,NCI,5R01CA132630-03,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$448,723"
Ovarian Cancer,2009,NCI,5R03CA136019-02,,Prolactin as a risk biomarker of ovarian cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$75,750"
Ovarian Cancer,2009,NCI,1R41CA132520-01A2,,Improving Ovarian Cancer Treatment by Targeting a Novel Epitope of MUC16,"KRAVITZ, RACHEL",NEOCLONE BIOTECHNOLOGY INTERNATIONAL,WI,"$190,591"
Ovarian Cancer,2009,NCI,1R41CA139802-01,,Exosomal microRNA profiles as diagnostic biomarkers of ovarian cancer,"TAYLOR, DOUGLAS","TEKSHIFA, INC.",KY,"$153,215"
Ovarian Cancer,2009,NCI,5K01CA115593-05,,The Role of X-linked Gene Expression in Mammary Tumorigenesis,"HUYNH, KHANH",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$152,523"
Ovarian Cancer,2009,NCI,5R33CA110499-03,,Molecular Profiling to Predict Response to Chemotherapy,"LANCASTER, JOHNATHAN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$271,683"
Ovarian Cancer,2009,NCI,1F31CA134188-01A1,,Boosting therapeutic immunity against Ovarian Cancer through CD40/TLR agonists,"SCARLETT, UCIANE",DARTMOUTH COLLEGE,NH,"$41,176"
Ovarian Cancer,2009,NCI,5R01CA123088-03,,Novel immunosupressive macrophages in human ovarian tumor,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$288,800"
Ovarian Cancer,2009,NICHD,5K12HD055881-03,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$50,000"
Ovarian Cancer,2009,OD,5K12HD055881-03,,VCU Building Interdisciplinary Research Careers in Women's Health,"STRAUSS, JEROME",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$446,801"
Ovarian Cancer,2009,NCI,5R21CA134960-02,,Novel Ovarian Cancer Detection Agents from Phage Display,"DEUTSCHER, SUSAN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$182,554"
Ovarian Cancer,2009,OD,5R21CA134960-02,,Novel Ovarian Cancer Detection Agents from Phage Display,"DEUTSCHER, SUSAN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$20,000"
Ovarian Cancer,2009,NCI,5K99CA133190-02,,Epidermal growth factor regulation of miR-125a promotes invasive ovarian cancer,"COWDEN DAHL, KAREN",UNIVERSITY OF NEW MEXICO,NM,"$122,783"
Ovarian Cancer,2009,NCI,5F31CA123637-04,,Ovarian Cancer Biomarker Discovery using scFv Arrays,"RAMIREZ, ARTURO",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$35,209"
Ovarian Cancer,2009,NCI,5K07CA108987-04,,Clinical Relevance of Mismatch Repair in Ovarian Cancer,"PAL, TUYA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$132,823"
Ovarian Cancer,2009,NCI,5R01CA095071-08,,Epithelial Positioning Organization and Ovarian Cancer,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$307,831"
Ovarian Cancer,2009,NIGMS,5F31GM078742-03,,Role of estrogen and its receptors in ovarian cancer of the hen,"TREVINO, LINDSEY",CORNELL UNIVERSITY ITHACA,NY,"$37,656"
Ovarian Cancer,2009,NCI,5K22CA121991-03,,Growth Inhibition Induced by Mifepristone in Ovarian Cancer,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$141,885"
Ovarian Cancer,2009,NCI,7R01CA127239-02,,pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics,"NATARAJAN, AMARNATH",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$273,497"
Ovarian Cancer,2009,NCI,5K07CA131094-02,,Epigentics and Female Reproductive Cancers,"PERRIN, MARY",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$139,320"
Ovarian Cancer,2009,NHGRI,5R03HG004528-02,,Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis For Inherited,"RUBIN, LISA",NEW SCHOOL UNIVERSITY,NY,"$77,250"
Ovarian Cancer,2009,NCI,5R01CA134487-02,,Mesothelin as biomarker and therapeutic target,"HELLSTROM, INGEGERD",UNIVERSITY OF WASHINGTON,WA,"$270,000"
Ovarian Cancer,2009,NCI,5R01CA095319-07,,Novel Fas/CD95 Signaling Mechanisms,"PETER, MARCUS",UNIVERSITY OF CHICAGO,IL,"$275,709"
Ovarian Cancer,2009,NCI,5R44CA103177-03,,Photodynamic Therapy of Disseminated Peritoneal Tumor Using New Photosensitizers,"WHARTON, J","LYNNTECH, INC.",TX,"$559,864"
Ovarian Cancer,2009,NCI,1SC2CA150317-01A2,,Role of Mitochondrial Genomic Alterations in Epithelial Ovarian Tumors,"AIKHIONBARE, FELIX",MOREHOUSE SCHOOL OF MEDICINE,GA,"$140,000"
Ovarian Cancer,2009,NCI,5R21CA116585-02,,Inflammatory Markers in Circulation and Ovarian Cancer Risk,"ARSLAN, ALAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$190,688"
Ovarian Cancer,2009,NCI,5R01CA120061-05,,Hormone levels during pregnancy and maternal ovarian cancer,"LUKANOVA, ANNEKATRIN",GERMAN CANCER RESEARCH CENTER,GERM,"$395,016"
Ovarian Cancer,2009,NCI,5R33CA122904-03,,Identification of T Cell-Defined Antigens in Ovarian Cancer,"YEE, CASSIAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$383,582"
Ovarian Cancer,2009,NHGRI,5R01HG005055-02,,INTERNET INTERVENTION FOR BRCA1/BRCA2 UNINFORMATIVES,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$544,846"
Ovarian Cancer,2009,NCI,1R44CA140047-01,,Cancer Progeniyor Cell Markers,"CHEN, WEN-TIEN","VITATEX, INC.",NY,"$99,378"
Ovarian Cancer,2009,NIAID,1SC1AI089073-01,,Roles of inflammation-driven chemokines in the pathogenesis of ovarian cancer,"SON, DEOK-SOO",MEHARRY MEDICAL COLLEGE,TN,"$355,027"
Ovarian Cancer,2009,NINR,5R01NR010735-02,,Web-Based Ovarian Cancer Symptom Control: Nurse-Guided vs. Self-Directed,"DONOVAN, HEIDI",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$567,469"
Ovarian Cancer,2009,OD,1R21CA141241-01,,Development and Pilot Test of an Elective BSO Decision Support Guide,"KUPPERMANN, MIRIAM",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$203,940"
Ovarian Cancer,2009,NCI,1R01CA140933-01,,Biobehavioral Influences and the Ovarian Tumor Microenvironment,"LUTGENDORF, SUSAN",UNIVERSITY OF IOWA,IA,"$599,954"
Ovarian Cancer,2009,NCI,1R01CA136494-01A1,,Molecular mechanism of antiangiogenic properties of gold nanoparticle,"MUKHERJEE, PRIYABRATA","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$282,179"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7923,Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer,"KAUFMANN, SCOTT","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$315,836"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7924,Mechanisms of Immune Suppression in Ovarian Cancer,"KNUTSON, KEITH","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$279,974"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7925,Optimizing Measles Virotherapy in the Treatment of Recurrent Ovarian Cancer,"GALANIS, EVANTHIA","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$398,680"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7926,Flavopiridol Reverses Platinum Resistance in Ovarian Cancer,"BIBLE, KEITH","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$278,870"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7927,Administration Core,"HARTMANN, LYNN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$206,920"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7928,Biospecimens/Patient Registry Core,"BELL, DEBRA%","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$205,612"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7929,Biostatistics Core,"OBERG, ANN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$218,809"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7930,Animal Models,"KNUTSON, KEITH","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$188,867"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7931,Developmental Research Program,"KAUFMANN, SCOTT","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$137,621"
Ovarian Cancer,2009,NCI,1P50CA136393-01A1,7932,Career Development Program,"COUCH, FERGUS","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$68,811"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7949,Gene Methylation Signatures for Predictive Classification of Response to Therapy,"CAIRNS, PAUL",FOX CHASE CANCER CENTER,PA,"$247,635"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7950,Improving the Estimation and Communication of Ovarian Cancer Risk Among BRCA1/2 C,"DALY, MARY",FOX CHASE CANCER CENTER,PA,"$357,347"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7951,Therapeutic Micro RNA Strategies for Ovarian Cancer,"HAMILTON, THOMAS",FOX CHASE CANCER CENTER,PA,"$423,111"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7952,Targeting Signaling Networks Via Novel RNAi Approaches to Improve Therapy for O,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$275,341"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7955,Advancing T cell Therapy for Ovarian Cancer,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$438,669"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7956,Administrative Core,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$120,056"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7957,Biosample and Tissue Procurement Core,"GODWIN, ANDREW",FOX CHASE CANCER CENTER,PA,"$142,672"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7958,Biostatistics and Bioinformatics Core,"ROSS, ERIC",FOX CHASE CANCER CENTER,PA,"$141,895"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7959,Developmental Research Program,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$61,309"
Ovarian Cancer,2009,NCI,2P50CA083638-11,7960,Career Development Program,"SEIDEN, MICHAEL",FOX CHASE CANCER CENTER,PA,"$91,965"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7964,Randomized Controlled Trial Novel Markers Predict Malignancy Elevated-Risk Women,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$149,101"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7965,Targeted Microbubble Contrast-Enhanced Ultrasound Imaging of the Ovarian Cancer V,"DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$282,947"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7966,MicroRNA Signature of Poorly Resectable Ovarian Cancer,"TEWARI, MUNEESH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$228,101"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7967,Clinical Implication of the Acquisition of BRCA1/2 Function in BRCA1/2-Deflcient,"TANIGUCHI, TOSHIYASU",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$285,004"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7968,Vaccinating against IGFBP-2 to prevent ovarian cancer relapse,"DISIS, MARY",UNIVERSITY OF WASHINGTON,WA,"$387,723"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7969,Leadership and Administration Core,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$80,720"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7970,Clinical Specimen Management and Characterization Core,"KNUDSEN, BEATRICE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$279,677"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7971,"Participant Recruitment, Enrollment and Characterization Core","DRESCHER, CHARLES",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$278,652"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7972,Biostatistics and Informatics Core,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$174,114"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7973,Developmental Research Program,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$72,322"
Ovarian Cancer,2009,NCI,2P50CA083636-11,7974,Career and Mentoring Development Program,"COLLINS, STEVEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$72,322"
Ovarian Cancer,2009,NCI,1R01CA136547-01A1,,Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer,"GALANIS, EVANTHIA","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$529,522"
Ovarian Cancer,2009,NCI,1R01CA136512-01A1,,BRCA1 Function in Post-Damage Nuclear Foci,"LIVINGSTON, DAVID",DANA-FARBER CANCER INSTITUTE,MA,"$443,843"
Ovarian Cancer,2009,NCI,1R01CA136491-01A1,,Development of an Assay for the Early Detection of Ovarian Cancer,"BRARD, LAURENT",WOMEN AND INFANTS HOSPITAL-RHODE ISLAND,RI,"$437,133"
Ovarian Cancer,2009,NCI,1R01CA136596-01A1,,"The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis","CONNOLLY, DENISE",FOX CHASE CANCER CENTER,PA,"$325,879"
Ovarian Cancer,2009,NIGMS,2R01GM088055-10A2,,Structural and Functional Characterization of BRCA1/BARD1,"KLEVIT, RACHEL",UNIVERSITY OF WASHINGTON,WA,"$409,735"
Ovarian Cancer,2009,NCI,2R01CA058598-11A2,,Collaborative Genetic Study of Ovarian Cancer Risk,"GOODMAN, MARC",UNIVERSITY OF HAWAII AT MANOA,HI,"$572,236"
Ovarian Cancer,2009,NCI,1R01CA131400-01A2,,VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER,"SPRINGETT, GREGORY",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,525"
Ovarian Cancer,2009,NCI,1R01CA131200-01A1,,Regulation of Ovarian Cancer Multidrug Resistance by MAP Kinases,"EBLEN, SCOTT",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$305,274"
Ovarian Cancer,2009,NCI,1R01CA126841-01A2,,Regulatory T Cell Function in Ovarian Cancer,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$562,552"
Ovarian Cancer,2009,NCI,1R01CA129142-01A2,,Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women,"KINNEY, ANITA",UNIVERSITY OF UTAH,UT,"$637,818"
Ovarian Cancer,2009,NCI,1R01CA138556-01A1,,Impact of exercise on ovarian cancer prognosis,"IRWIN, MELINDA",YALE UNIVERSITY,CT,"$686,732"
Ovarian Cancer,2009,NCI,1R01CA135006-01A2,,Role of TbRIII in Regulating Motility and Invasion,"BLOBE, GERARD",DUKE UNIVERSITY,NC,"$433,023"
Ovarian Cancer,2009,NCI,1R21CA132026-01A1,,Boosting anti-tumor immune responses by modulating genes with nanoparticles,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$179,782"
Ovarian Cancer,2009,NCI,1K99CA134750-01A1,,The Role of the Microenvironment in Early Ovarian Cancer Metastasis,"KENNY, HILARY",UNIVERSITY OF CHICAGO,IL,"$109,088"
Ovarian Cancer,2009,NCI,1R01CA133117-01A2,,Role of the Mullerian Tract in Ovarian Cancer Development,"DUBEAU, LOUIS",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$338,225"
Ovarian Cancer,2009,NCI,1R01CA135179-01A2,,INTERNET DECISION SUPPORT FOR BRCA1/BRCA2 CARRIERS,"SCHWARTZ, MARC",GEORGETOWN UNIVERSITY,DC,"$544,600"
Ovarian Cancer,2009,NCI,1R01CA137041-01A1,,MicroRNAs in Human Ovarian Cancer,"CHENG, JIN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$346,352"
Ovarian Cancer,2009,NCI,1R43CA141747-01,,A nanoparticle prognosticator of chemotherapy outcomes,"LEBOVITZ, RUSSELL","MARVAL BIOSCIENCES, INC.",TX,"$139,513"
Ovarian Cancer,2009,NCI,5P30CA006516-45,9035,Core - Rapid Case Identification,"MUELLER, NANCY",DANA-FARBER CANCER INSTITUTE,MA,"$222,707"
Ovarian Cancer,2009,NCI,2R42CA124191-02A1,,BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test,"HOLT, JEFFREY","TISSUE GENETICS, INC.",CO,"$299,203"
Ovarian Cancer,2009,NCI,1R43CA135960-01A1,,Portable photonic sensor system as an early detection tool for ovarian cancer,"WAWRO, DEBRA",RESONANT SENSORS INC.,TX,"$212,385"
Ovarian Cancer,2009,NCI,1R43CA132395-01A2,,Development of therapeutic monoclonal antibody to the bioactive lipid lysophospha,"MATTEO, ROSALIA","LPATH THERAPEUTICS, INC.",CA,"$139,523"
Ovarian Cancer,2009,NCI,1R13CA142030-01,,Symposium on Hereditary Breast & Ovarian Cancers:  Risk and Challenges,"MUGGIA, FRANCO",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$12,500"
Ovarian Cancer,2009,NCI,1R03CA142074-01,,Prevention of Menopause-Related Ovarian Epithelial Cancer,"SMITH, ELIZABETH",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$76,500"
Ovarian Cancer,2009,NCI,1F32CA142117-01,,Modulation of tumor-associated macrophage phenotype by S1P receptors,"BLAHO, VICTORIA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$50,054"
Ovarian Cancer,2009,NCI,5P30CA014236-35,0010,BREAST AND OVARIAN ONCOLOGY,"LYERLY, HERBERT",DUKE UNIVERSITY,NC,"$37,597"
Ovarian Cancer,2009,NCI,3R01CA119388-04S1,,Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$30,000"
Ovarian Cancer,2009,NCI,5P30CA014089-34,9001,Molecular and Cell Biology,"LANDOLPH, JOSEPH",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$445,809"
Ovarian Cancer,2009,NCI,5P30CA014089-34,9005,Transgenic/Knockout Mouse Core Facility,"MAXSON, ROBERT",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$259,440"
Ovarian Cancer,2009,NCI,4R44CA123785-02,,Fast-Track:Biomagnetic In-vivo Imaging of Ovarian Cancer,"FLYNN, EDWARD",SENIOR SCIENTIFIC,NM,"$371,745"
Ovarian Cancer,2009,NCI,1R03CA139492-01A1,,"Ovulation, inclusion cysts, and p53 mutations in a mouse model of ovarian cancer","BURDETTE, JOANNA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$78,500"
Ovarian Cancer,2009,NCI,5P01CA087969-10,0007,"HORMONES, DIET AND RISK OF OVARIAN CANCER","HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$241,637"
Ovarian Cancer,2009,NCI,5P01CA087969-10,0008,STATISTICAL INNOVATIONS IN RISK MODELING,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$155,718"
Ovarian Cancer,2009,NCI,1F31CA144083-01,,Defining double-stranded RNA receptor induced apoptosis in ovarian cancer.,"SCHRAMM, DANIELLE",VIRGINIA COMMONWEALTH UNIVERSITY,VA,"$32,266"
Ovarian Cancer,2009,NCI,1F33CA144208-01,,Role and regulation of GnRH and receptors in Cisplatin resistant ovarian cancer,"SRIDARAN, RAJAGOPALA",OTTAWA HEALTH RESEARCH INSTITUTE,CANADA,"$54,820"
Ovarian Cancer,2009,NCI,5U19CA113341-05,0002,OVARIAN CANCER MESOTHELIN ANIMAL MODEL/DNA VACCINES,"WU, T.-C.",JOHNS HOPKINS UNIVERSITY,MD,"$234,577"
Ovarian Cancer,2009,NCI,5U19CA113341-05,0003,EVALUATE LAG3 AND OTHER IMMUNE MODULATORS,"PARDOLL, DREW",JOHNS HOPKINS UNIVERSITY,MD,"$230,904"
Ovarian Cancer,2009,NCI,5U19CA113341-05,0004,EVALUATE B7H1/H4 IN MOUSE MODELS AND IN HUMAN PRE-CLINICAL STUDIES,"CHEN, LIEPING",JOHNS HOPKINS UNIVERSITY,MD,"$234,891"
Ovarian Cancer,2009,NCI,N44CN73301-4-0-1,,Biomarker Screening with Revoluntionary Neoabs,"MULLER, UWE",NEOCLONE BIOTECHNOLOGY INTERNATIONAL,WI,"$35,615"
Ovarian Cancer,2009,NCI,261200800045C-2-0-1,,Improvement of a Promising MAP for Ovarian Cancer,"STEPHEN, LAURIE","RULES-BASED MEDICINE, INC.",TX,"$998,714"
Ovarian Cancer,2009,NCI,5P01CA070970-11,0006,Cancer Stem Cells in Acute Lymphoblastic Leukemia and Ovarian Carcinoma,"JONES, RICHARD",JOHNS HOPKINS UNIVERSITY,MD,"$347,701"
Ovarian Cancer,2009,NCI,N1CN75022A-63-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$692,835"
Ovarian Cancer,2009,NCI,N1CN25524A-78-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$734,554"
Ovarian Cancer,2009,NCI,N1CN25518A-92-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$767,995"
Ovarian Cancer,2009,NCI,N1CN25516A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,WASHINGTON UNIVERSITY,MO,"$611,560"
Ovarian Cancer,2009,NCI,N1CN25515A-87-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH INSTITUTE,HI,"$1,078,239"
Ovarian Cancer,2009,NCI,N1CN25514A-82-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$1,327,312"
Ovarian Cancer,2009,NCI,N1CN25513A-93-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,465,095"
Ovarian Cancer,2009,NCI,N1CN25512A-107-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$1,138,422"
Ovarian Cancer,2009,NCI,N1CN25511A-88-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","WEISSFELD, JOEL",,,"$632,887"
Ovarian Cancer,2009,NCI,3R01CA115483-05S2,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$60,652"
Ovarian Cancer,2009,NCI,N02CN63300-4-0-4,,Computer Support for Ovarian Cancer Screening in PLCO Cancer Screening Trials,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$348,161"
Ovarian Cancer,2009,NCI,5P01CA078039-10,0002,Molecular Pharmacology & Biochemistry of Dual Specificity Phosphatase Inhibitors,"LAZO, JOHN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$300,978"
Ovarian Cancer,2009,NCI,3R01CA017393-34S1,,Mullerian Inhibiting Substance,"DONAHOE, PATRICIA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$130,442"
Ovarian Cancer,2009,NCI,5P01CA042745-23,0014,LIPOSOMES,"DEWHIRST, MARK",DUKE UNIVERSITY,NC,"$188,855"
Ovarian Cancer,2009,NCI,5P30CA006927-47,9036,CORE--TRANSGENIC MOUSE,"YOUNG, ROBERT",FOX CHASE CANCER CENTER,PA,"$158,230"
Ovarian Cancer,2009,NCI,5P30CA006927-47,9037,CORE--POPULATION STUDIES,"YOUNG, ROBERT",FOX CHASE CANCER CENTER,PA,"$321,198"
Ovarian Cancer,2009,NCI,7R01CA116984-04,,G Proteins and Their Receptors in Tumor Cell Metastasis,"DHANASEKARAN, DANNY",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$305,220"
Ovarian Cancer,2009,NCI,N1CN25476A-81-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$2,102,638"
Ovarian Cancer,2009,NCI,5U54CA096297-07,0008,"Synthesis and Pre-Clinical Evaluation of Targeted, Iron-Based MRI Contrast Agents","RAPTIS, RAPHAEL",UNIVERSITY OF PUERTO RICO,PR,"$145,941"
Ovarian Cancer,2009,NCI,5P01CA052477-17,0006,The Molecular Genetics of MUC16,"BOYD, JEFFREY",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$429,159"
Ovarian Cancer,2009,NCI,5P01CA052477-17,0007,Development of Antibody and T-Cell Inducing Vaccines,"LIVINGSTON, PHILIP",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$659,761"
Ovarian Cancer,2009,NCI,5P01CA052477-17,0008,Cellular Immunity Targeting Epithelial Ovarian Cancer,"O'REILLY, RICHARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$362,183"
Ovarian Cancer,2009,NCI,5P01CA052477-17,0009,Novel Strategy for the Re-Induction & Consolidation of Remission in Ovary Cancer,"SPRIGGS, DAVID",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$236,234"
Ovarian Cancer,2009,NCI,5P01CA052477-17,9002,Core--Biostatistics,"THALER, HOWARD",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$230,750"
Ovarian Cancer,2009,NCI,5P01CA052477-17,9003,Core--Pathology,"SOSLOW, ROBERT",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$167,901"
Ovarian Cancer,2009,NCI,5P01CA129186-03,0002,"HOMOLOGY- DEPENDENT DNA REPAIR, HYPOXIA, AND CANCER THERAPY","GLAZER, PETER",YALE UNIVERSITY,CT,"$315,197"
Ovarian Cancer,2009,NCI,5P01CA017054-31,0001,Hormone Therapy and Risk of Ovarian Cancer,"WU, ANNA",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$432,035"
Ovarian Cancer,2009,NCI,5P01CA104177-05,0003,MDA-7/IL-24: Therapy of Ovarian Cancer,"CURIEL, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$338,625"
Ovarian Cancer,2009,NCI,5P01CA104177-05,9001,Core--Protein Purification,"GUPTA, PANKAJ",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$115,026"
Ovarian Cancer,2009,NCI,5P01CA104177-05,9002,Core--Viral Vector,"CURIEL, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$109,577"
Ovarian Cancer,2009,NCI,N1CN25522A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$649,306"
Ovarian Cancer,2009,NICHD,7R01HD057110-02,,Molecular Pathways Controlling Ovarian Gene Expression,"STOCCO, CARLOS",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$225,316"
Ovarian Cancer,2009,NCI,3R01CA060651-17S2,,Mouse Models to Study Gonadal Tumor Development,"MATZUK, MARTIN",BAYLOR COLLEGE OF MEDICINE,TX,"$32,447"
Ovarian Cancer,2009,NCI,5U54CA119349-05,0004,DISCRETE SENSOR DEVICES FOR DETERMINING CANCER TARGETS,"CIMA, MICHAEL",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$423,202"
Ovarian Cancer,2009,NCI,5U54CA119349-05,9005,MOUSE MODEL CORE,"HOUSMAN, DAVID",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$196,460"
Ovarian Cancer,2009,NCI,3P50CA083639-09S1,,University of Texas MD Anderson SPORE in Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$57,442"
Ovarian Cancer,2009,NCI,3R01CA095071-08S1,,Epithelial Positioning Organization and Ovarian Cancer,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$85,680"
Ovarian Cancer,2009,NIAID,5P01AI068730-03,0005,COMPLEMENT IN CANCER ESTABLISHMENT AND GROWTH,"COUKOS, GEORGE",UNIVERSITY OF PENNSYLVANIA,PA,"$133,261"
Ovarian Cancer,2009,NCI,N1CN25404A-41-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Lab",NO PI IDENTIFIED,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$932,550"
Ovarian Cancer,2009,NCI,3R21CA137686-01S1,,High-throughput intracellular microrheology: a new tool for cancer research,"WIRTZ, DENIS",JOHNS HOPKINS UNIVERSITY,MD,"$67,326"
Ovarian Cancer,2009,NCI,5U54CA119341-05,0001,Development of BarCode Assays for the Detection of Ovarian Cancer,"MIRKIN, CHAD",NORTHWESTERN UNIVERSITY,IL,"$645,897"
Ovarian Cancer,2009,NCI,3P50CA105009-05S1,,Dana-Farber/Harvard Cancer Center Ovarian Cancer SPORE,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,193,174"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0007,Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$414,975"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0008,Cell-specific Targeting of Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$266,949"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0009,Development of E1A Gene Therapy in Ovarian Cancer,"HUNG, MIEN-CHIE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$211,121"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0010,Targeting the PI3K Pathway in Ovarian Cancer,"MILLS, GORDON",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$211,121"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0011,Developmental Research Program,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$177,918"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0012,Career Development Program,"BAST, ROBERT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$177,919"
Ovarian Cancer,2009,NCI,5P50CA083639-10,0013,Genome Based Marker and Therapy Development in Ovarian Cancer,"GRAY, JOE",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$326,685"
Ovarian Cancer,2009,NCI,5P50CA083639-10,9003,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$27,994"
Ovarian Cancer,2009,NCI,5P50CA083639-10,9004,Biostatistics Core,"ATKINSON, E",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$177,658"
Ovarian Cancer,2009,NCI,5P50CA083639-10,9005,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$207,660"
Ovarian Cancer,2009,RMAP,3R01CA132630-03S1,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$87,829"
Ovarian Cancer,2009,RMAP,3R01CA132630-03S2,,Chemical Probes for Metabolic Pathway Discovery in Human Disease,"CRAVATT, BENJAMIN",SCRIPPS RESEARCH INSTITUTE,CA,"$88,039"
Ovarian Cancer,2009,NHLBI,268200900004C-1-0-1,,BIOMEDICAL (BASIC),"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$568,001"
Ovarian Cancer,2009,NCRR,5M01RR000400-41,7085,MT2007-19R: WCC #53 ALLOGENEIC NATURAL KILLER CELLS IN PATIENTS WITH RECURRENT O,"GELLER, MELISSA",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$8,050"
Ovarian Cancer,2009,NCI,261200900044C-0-0-1,,Health Information Technology to Facilitate Patient-centered Communication in Can,"YANG, DERSHUNG","CARACAL, INC.",IL,"$149,992"
Ovarian Cancer,2009,NCRR,5M01RR000071-46,7843,"SURGERY, PSYCHOLOGY, & BLOOD CLOTTING IN WOMEN WITH GYNECOLOGIC PROCEDURES","HIGGINS, SARA",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,$490
Ovarian Cancer,2009,NCRR,5P41RR008079-17,5206,DIAGNOSTIC MRI AND SPECTROSCOPY OF THE OVARIES AT 3 TESLA,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$12,835"
Ovarian Cancer,2009,NCRR,5P41RR008079-17,5244,MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY OF THE OVARIES AT 3 TESLA,"DOWNS, LEVI",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$12,835"
Ovarian Cancer,2009,NCRR,5P41RR011823-14,8036,IDENTIFYING MEIOSIS-SPECIFIC SUBSTRATES OF CLB5-CDK1,"STUART, DAVID",UNIVERSITY OF WASHINGTON,WA,"$3,309"
Ovarian Cancer,2009,NCRR,2P51RR000163-50,8670,"FEMALE ANDROGEN:  METABOLIC SYNDROME, CARDIOVASCULAR DISEASE, OVARIAN CANCER","STOUFFER, RICHARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$78,561"
Ovarian Cancer,2009,NIA,2P51RR000163-50,8670,"FEMALE ANDROGEN:  METABOLIC SYNDROME, CARDIOVASCULAR DISEASE, OVARIAN CANCER","STOUFFER, RICHARD",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,782"
Ovarian Cancer,2009,NCRR,2P51RR000163-50,8699,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$78,561"
Ovarian Cancer,2009,NIA,2P51RR000163-50,8699,BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,782"
Ovarian Cancer,2009,NCRR,2P51RR000163-50,8736,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$33,706"
Ovarian Cancer,2009,NIA,2P51RR000163-50,8736,NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION,"WRIGHT, JAY",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,$765
Ovarian Cancer,2009,NCRR,5G12RR003032-25,5419,DISSECTING COX-1 RELATED GENE PATHWAYS IN OVARIAN CANCER,"KHABELE, DINEO",MEHARRY MEDICAL COLLEGE,TN,"$72,316"
Ovarian Cancer,2009,NCRR,5G12RR003037-25,5439,ROLES OF MSP58 IN NUCLEAR FUNCTION AND ONCOGENESIS,"ZHONG, HUALIN",HUNTER COLLEGE,NY,"$113,523"
Ovarian Cancer,2009,NCRR,5P20RR015578-10,5528,GONAD-SPECIFIC TRANSCRIPTION FACTORS,"FREIMAN, RICHARD",BROWN UNIVERSITY,RI,"$233,467"
Ovarian Cancer,2009,NCRR,2P20RR016481-09,6299,MECHANISMS OF ACTION OF UMUD IN REGULATING DNA DAMAGE-INDUCED GENES IN A UMUC-DE,"HARE, JANELLE",UNIVERSITY OF LOUISVILLE,KY,"$95,712"
Ovarian Cancer,2009,NCRR,2P20RR016477-09,6474,SIGNALING PATHWAYS IN APIGENIN-INHIBITING TUMOR GROWTH,"CHEN, ALLAN",MARSHALL UNIVERSITY,WV,"$166,860"
Ovarian Cancer,2009,NCRR,2P20RR016479-09,6481,ANTI-OVARIAN CANCER PROPERTIES OF RU-486,"TELLERIA, CARLOS",UNIVERSITY OF SOUTH DAKOTA,SD,"$34,658"
Ovarian Cancer,2009,NCRR,2P20RR016474-09,6507,OVARIAN CANCER: PREVENTION AND TREATMENT,"MURDOCH, WILLIAM",UNIVERSITY OF WYOMING,WY,"$320,842"
Ovarian Cancer,2009,NIA,1ZIAAG000395-02,,Expression and roles of claudin-3 and claudin-4 in ovarian cancer,"MORIN, PATRICE",NIH,,"$618,875"
Ovarian Cancer,2009,NIA,1ZIAAG000396-02,,Mechanisms of drug resistance in ovarian cancer,"MORIN, PATRICE",NIH,,"$277,427"
Ovarian Cancer,2009,NIA,1ZIAAG000397-02,,Claudin-7 in ovarian cancer,"MORIN, PATRICE",NIH,,"$213,405"
Ovarian Cancer,2009,NIA,1ZIAAG000398-02,,Expression and roles of microRNAs in ovarian tumorigenesis,"MORIN, PATRICE",NIH,,"$213,405"
Ovarian Cancer,2009,NCI,1ZIABC010549-07,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$1,223,960"
Ovarian Cancer,2009,NCI,1ZIABC010696-05,,Study of Hereditary Renal and Other Familial Syndromes,"MERINO NEUMANN, MARIA",NIH,,"$390,074"
Ovarian Cancer,2009,NCI,1ZIABC010891-02,,Antibody Therapy of Cancer,"HO, MITCHELL",NIH,,"$661,164"
Ovarian Cancer,2009,NCI,1ZIABC010935-02,,Regulation of Metastasis and Angiogenesis by Autotaxin and its Products,"STRACKE, MARY",NIH,,"$459,314"
Ovarian Cancer,2009,NCI,1ZIABC011054-02,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$659,547"
Ovarian Cancer,2009,NCI,1ZIABC011164-01,,Expression profiles in ATL Patients,"BRADY, JOHN",NIH,,"$177,334"
Ovarian Cancer,2009,NCI,1ZIABC011188-01,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$585,804"
Ovarian Cancer,2009,NCI,1ZIABC011197-01,,Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells,"APPELLA, ETTORE",NIH,,"$419,401"
Ovarian Cancer,2009,NCI,1ZIACP010190-04,,Genetic Epidemiology of Telomere Maintenance and Cancer Etiology,"SAVAGE, SHARON",NIH,,"$34,100"
Ovarian Cancer,2009,NIDDK,1ZIADK047039-03,,Mechanism of action of STAMP - a new comodulator of glucocorticoid receptors,"SIMONS, S STONEY",NIH,,"$297,060"
Ovarian Cancer,2009,NHGRI,1ZIAHG000120-13,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$190,362"
Ovarian Cancer,2009,NCI,1ZIASC000165-18,,The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis,"BIRRER, MICHAEL",NIH,,"$186,717"
Ovarian Cancer,2009,NCI,1ZIASC000181-17,,The Molecular Genetics of Gynecologic Cancers,"BIRRER, MICHAEL",NIH,,"$280,075"
Ovarian Cancer,2009,NCI,1ZIASC007263-17,,TRAIL-induced Cell Death in Breast Cancer Cells,"LIPKOWITZ, STANLEY",NIH,,"$428,477"
Ovarian Cancer,2009,NCI,1ZIASC009163-22,,Signal Transduction Therapy--Basic Science,"KOHN, ELISE",NIH,,"$172,231"
Ovarian Cancer,2009,NCI,1ZIASC009374-18,,Signaling Pathways as Molecular Targets in Angiogenesis and Microenvironment,"KOHN, ELISE",NIH,,"$180,842"
Ovarian Cancer,2009,NCI,1ZIASC009375-17,,Signal Transduction Therapy--Clinical,"KOHN, ELISE",NIH,,"$353,072"
Ovarian Cancer,2009,NCRR,5M01RR000043-49,8666,CLINICAL TRIAL: PHASE I TRIAL OF INTRAVENOUS FENRETINIDE (4-HPR) FOR PATIENTS WI,"YANG, ALLEN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$19,712"
